SOMO Logo
  • Research
    • Access to remedy
    • Climate Justice
    • Companies
    • Corporate accountability and regulation
    • Corporate lobby
    • Electronics
    • Energy
    • Extractives
    • Financial sector
    • Food and agriculture
    • Garments and textiles
    • Land
    • Multinationals and conflict
    • Pharmaceutical industry
    • Precarious work
    • Sustainable public procurement
    • Tax
    • Trade and investments
  • Services
    • Services
    • Our Services
      • Custom research
      • Training
      • Advice
    • Our team
    • Clients
    • The way we work
    • Get in touch
  • Network
  • About SOMO
    • About SOMO
    • Mission & vision
    • Team
    • Funders
    • Work at SOMO
    • Frequently Asked Questions
  • Support us
    • Support us
    • Donate
    • Publeaks
  • Contact
  • en
  • nl
Contact
Wemos
Ellermanstraat 15-O, 1114 AK, Amsterdam-Duivendrecht, .
Share Menu
Share this
  • twitter Created with Sketch.
  • facebook Created with Sketch.
  • linkedin Created with Sketch.
  • email Created with Sketch.
  • print Created with Sketch.
Home Wemos
Organisation

Wemos

related content

News / July 13, 2021

Moderna vaccine profits channelled to tax havens

Vaccine manufacturer Moderna is employing tax avoidance structures to shift its profits to Switzerland and the US state of Delaware, research by SOMO in cooperation with Wemos. The European Union ordered $10.3 billion worth of…

Long read / July 13, 2021

Moderna’s free ride

Pocketing tax free profits from publicly funded jabs
Long read / March 7, 2021

How can we make publicly funded corona vaccines accessible to all?

Statement / February 4, 2021

Global vaccine scarcity unnecessary if pharma shares knowledge

In a joint letter, SOMO together with 53 civil society organisations are calling upon the Dutch government to ensure that pharmaceutical companies share their knowledge of vaccine development with other companies in an existing pool…

Prescription prices
News / October 2, 2020

Response of SOMO and Wemos to Government reaction on report ‘Overpriced’

On 27 August 2020, the Dutch Ministry of Economic Affairs responded in a letter to the Parliament to the SOMO report ‘Overpriced: drugs developed with Dutch Public Funding‘. On our Dutch website you find a…

News / October 2, 2020

New research reveals large-scale tax avoidance by coronavirus test manufacturer Qiagen

New research by the Centre for Research on Multinational Corporations (SOMO) shows that the German coronavirus test producer Qiagen has been able to dodge millions of euros in tax since 2010 thanks to tax avoidance…

publication cover - Profiting from a pandemic
Publication / October 2, 2020

Profiting from a pandemic

How COVID-19 test kit producer Qiagen receives public money but avoids taxes
publication cover - Profiting from a pandemic
Download
Result / July 8, 2020

Dutch parliament supports resolution on affordable and accessible corona vaccines

News / September 4, 2019

Webinar on public investment in medicines in Europe

The European Alliance for Responsible R&D and Affordable medicines organised in cooperation with Wemos, SOMO, Salud por Derecho, StopAids and Global Justice Now a webinar on public investments in biomedical research and development (R&D). The…

Result / August 13, 2019

Overpriced drugs: SOMO and Wemos publication discussed in Dutch parliament

SOMO Logo

Come and visit us

Centre for Research on Multinational Corporations (SOMO)
KNSM-laan 17
1019 LA, Amsterdam
Nederland
view on google maps

Contact us

Tel: +31 (0)20 639 12 91 (Mon-Fri, 9AM-5PM)
Email: info@somo.nl
Visit our twitter page Visit our facebook page Visit our linkedin page Visit our mastadon page Visit our youtube page

Practical details

Bank name: Triodos
Account number: NL56TRIO0198407777
BIC / SWIFT code: TRIONL2U
VAT number: NL002954631B01
Chamber of Commerce registration: 41223308

  • Disclaimer
  • Privacy statement
  • Cookie Policy
ANBI Logo ISO Logo Partos Logo
Cookies & Privacy
We use cookies to optimise your experience and improve our website.
Functional Always active
These cookies are required in order to use the website. They ensure that the website works properly and that your user preferences remain known. For example, they save you from having to enter the same information every time you visit our website. We may set these cookies without your consent.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
These cookies collect information about how you use our website, such as which pages you visited and which links you clicked. This information is only used for reporting and improving website functions. All data is anonymised, so the information cannot be used to identify you. We do not share statistical data with third parties. These cookies collect information about how you use our website, such as which pages you visited and which links you clicked. This information is only used for reporting and improving website functions. All data is anonymised, so the information cannot be used to identify you. We do not share statistical data with third parties.
Marketing
These cookies track your online activity to help advertisers deliver more relevant advertising or to limit how many times you see an ad. Marketing cookies may share that information with other websites, organisations or advertisers.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}